Trial Profile
The Human Mucosal Immune Responses to Influenza Virus: A Systems Biology Approach. Innate Immune Responses to Influenza Virus in Single Human Nasal Epithelial Cells
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2017
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms SLVP026
- 20 Jan 2017 New trial record